follow-up period

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study

Study Overview This study investigates the comparative risks associated with dementia and Parkinson’s disease in obese individuals suffering from type

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study Read Post »

Lower Risk of Incident Dementia with SGLT2 Inhibitor Versus DPP-4 Inhibitor Initiation in Patients with Type 2 Diabetes and Prior Traumatic Brain Injury: A Retrospective Cohort Study

Study Overview The research investigates the potential impact of two classes of medications, SGLT2 inhibitors and DPP-4 inhibitors, on the

Lower Risk of Incident Dementia with SGLT2 Inhibitor Versus DPP-4 Inhibitor Initiation in Patients with Type 2 Diabetes and Prior Traumatic Brain Injury: A Retrospective Cohort Study Read Post »

Evaluating inclusion of continuous multivariable cognitive scores for operational enrichment of preclinical Alzheimer’s disease trials: a retrospective emulation study

Study Overview The study investigates the effectiveness of using continuous multivariable cognitive scores to enhance the enrichment of preclinical trials

Evaluating inclusion of continuous multivariable cognitive scores for operational enrichment of preclinical Alzheimer’s disease trials: a retrospective emulation study Read Post »

Scroll to Top